These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 11370223)

  • 1. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
    Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
    G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute pancreatitis: clinical and therapeutic study with somatostatin].
    Sánchez Rodríguez A; Sánchez Fuentes D; Chimpén Ruiz V; Martín Oterino JA; Araoz Sánchez P; de Portugal Alvarez J
    Rev Clin Esp; 1997 Feb; 197(2):96-9. PubMed ID: 9213864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis.
    Paran H; Neufeld D; Mayo A; Shwartz I; Singer P; Kaplan O; Skornik Y; Klausner J; Freund U
    J Am Coll Surg; 1995 Aug; 181(2):121-4. PubMed ID: 7627383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pancreatitis in intensive care unit patients: value of clinical and radiologic prognosticators at predicting clinical course and outcome.
    Liu TH; Kwong KL; Tamm EP; Gill BS; Brown SD; Mercer DW
    Crit Care Med; 2003 Apr; 31(4):1026-30. PubMed ID: 12682467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative treatment of acute pancreatitis: the use of somatostatin.
    Ladas SD; Raptis SA
    Hepatogastroenterology; 1992 Oct; 39(5):466-9. PubMed ID: 1360937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute pancreatitis. Our experience during 20 years].
    Amboldi A; Musazzi M; Cornelli A; Perone C; Merloni T; Gomarasca I; Bonvini S; Zanotti M
    Minerva Chir; 1999 May; 54(5):305-12. PubMed ID: 10443109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabexate mesilate in the treatment of acute pancreatitis.
    Pederzoli P; Bassi C; Falconi M; De Santis L; Uomo G; Rabitti PG; Talamini G; Cavallini G
    Ann Ital Chir; 1995; 66(2):191-5. PubMed ID: 7545361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches for the treatment of acute pancreatitis.
    Pezzilli R; Fantini L; Morselli-Labate AM
    JOP; 2006 Jan; 7(1):79-91. PubMed ID: 16407625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
    Freise J; Melzer P; Schmidt FW; Horbach L
    Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Poon RT; Fan ST
    JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of a clinical protocol in the treatment of severe acute pancreatitis].
    Pupelis G; Austrums E; Snippe K
    Zentralbl Chir; 2002 Nov; 127(11):975-81. PubMed ID: 12476372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of somatostatin on immune inflammatory response in patients with severe acute pancreatitis.
    Tang WF; Wang YG; Zhu L; Wan MH; Chen GY; Xia Q; Ren P; Huang X
    J Dig Dis; 2007 May; 8(2):96-102. PubMed ID: 17532822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of somatostatin analogues in the management of enterocutaneous fistulae.
    Jamil M; Ahmed U; Sobia H
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):237-40. PubMed ID: 15228830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of octreotide on the clinical course of acute pancreatitis and levels of free oxygen radicals and antioxidants].
    Lata J; Dítĕ P; Julínková K; Precechtĕlová M; Prásek J
    Vnitr Lek; 1998 Sep; 44(9):524-7. PubMed ID: 10358462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders.
    Friess H; Büchler MW
    Digestion; 1996; 57 Suppl 1():97-102. PubMed ID: 8813484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis of acute pancreatitis: Ranson or APACHE II?].
    Paredes Cotoré JP; Bustamante Montalvo M; Fernández Rodríguez E; Valeiras Domínguez E; Potel Lesquereux J
    Rev Esp Enferm Dig; 1995 Feb; 87(2):121-6. PubMed ID: 7748704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats.
    Paran H; Klausner J; Siegal A; Graff E; Freund U; Kaplan O
    J Surg Res; 1996 May; 62(2):201-6. PubMed ID: 8632640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors in severe acute pancreatitis. Univariate and multivariate study].
    Padillo FJ; Rufián S; Briceño J; Izquierdo N; Varo E; Miño G; Pera Madrazo C
    Rev Esp Enferm Dig; 1995 Jan; 87(1):32-7. PubMed ID: 7727165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.